Key result
A critical care pharmacist in the ICU was associated with a higher percentage of improved or resolved clinical outcomes related to averted medication errors compared to control (34% vs 15.2%, P=0.013).
Why the study?
Does the presence of a critical care pharmacist reduce medication errors and improve clinical outcomes in the ICU?
Population
Patients in the intensive care unit (ICU) setting
Comparison
Presence of a critical care pharmacist vs Control phase without a critical care pharmacist
Design
Cohort
Follow-up
8 weeks per phase
Authors
Loading...
Supports ICU pharmacist roles for medication safety; hypothesis-generating and requires randomized confirmation before practice change.
Observational
Does the presence of a critical care pharmacist reduce medication errors and improve clinical outcomes in the ICU?
Absolute Event Rate: 34% vs 15.2%
p-value: p=0.013
The presence of a critical care pharmacist in the ICU improves medication safety by identifying and preventing medication errors, leading to better clinical outcomes.
Lee et al. (2007) conducted an observational in Intensive care unit patients. Critical care pharmacist vs. Control phase without a critical care pharmacist was evaluated on Improved or resolved clinical outcomes related to averted medication errors (p=0.013). A critical care pharmacist in the ICU was associated with a higher percentage of improved or resolved clinical outcomes related to averted medication errors compared to control (34% vs 15.2%, P=0.013).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: